Carina Biotech to Present Preclinical Data at Lorne Cancer
Preclinical evidence shows that LGR5 targeted CAR-T cells are able to kill ovarian cancer cells and to reduce ovarian
Globe Newswire7-02-2023, 06:22
Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness 12-06-2023, 13:00